Related Experiment Videos
Prognostic factors in human colorectal cancer
A R Bianco1, C Carlomagno, M De Laurentiis
1Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Facoltà di Medicina e Chirurgia, Università degli Studi Federico II, Napoli, Italy.
Tumori
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab.
ESMO gastrointestinal oncology·2026
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approach.
ESMO real world data and digital oncology·2026
Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania region.
ESMO real world data and digital oncology·2026